Loading logo

Carbidopa Impurities

Carbidopa is a peripheral dopa-decarboxylase inhibitor commonly used in combination with Levodopa for the treatment of Parkinson's disease, helping to enhance Levodopa’s effectiveness by preventing its premature conversion to dopamine outside the brain. By doing so, it increases dopamine availability in the central nervous system while reducing side effects like nausea. Maintaining the pharmaceutical purity of Carbidopa is essential to ensure therapeutic efficacy, minimize adverse effects, and comply with regulatory standards. Impurity profiling is crucial to detect and control any undesirable substances generated during its manufacturing or storage. Here are some of its known impurities listed below.

Showing 1 - 8 of 8 products
Carbidopa
Catalogue No : CARB-OCL-008

CAS No : 28860-95-9

In Stock
Synonyms
(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid monohydrate
Carbidopa (Monohydrate)
Catalogue No : CARB-OCL-001

CAS No : 38821-49-7

In Stock
Synonyms
(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid monohydrate
Carbidopa EP Impurity A
Catalogue No : CARB-OCL-002

CAS No : N/A

In Stock
Synonyms
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid hydrate
Carbidopa EP Impurity B
Catalogue No : CARB-OCL-003

CAS No : 18181-08-3

In Stock
Synonyms
Methyl (2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate
Carbidopa EP Impurity E
Catalogue No : CARB-OCL-004

CAS No : 52514-63-3

In Stock
Synonyms
Methyl (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoate
Carbidopa EP Impurity F
Catalogue No : CARB-OCL-005

CAS No : 91908-71-3

In Stock
Synonyms
Ethyl (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoate
Carbidopa RC 11
Catalogue No : CARB-OCL-006

CAS No : 158190-23-9

In Stock
Synonyms
Methyl 2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate
Carbidopa RC 7
Catalogue No : CARB-OCL-007

CAS No : 302-53-4

In Stock
Synonyms
3-(3,4-Dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid